14 important things you should know about Allianz Funds HLHIX mutual fund

Updated: June 28, 2020
78

Before we start: if you’re looking for HLHIX “stock” price, you can quickly find it out by visiting Finny and typing "HLHIX quote". If you’re looking for a quick scoop on HLHIX "stock" (price chart, key stats, buy or sell analysis and holdings), go to Finny and look for "HLHIX". You’ll get all this info in one place.

Are you looking to buy or sell HLHIX? Or perhaps you’re looking for HLHIX fact sheet, and learn about its alternatives? If so, you came to the right place.

In this HLHIX mutual fund review, we’ll address key questions our readers have been asking us about this fund, above and beyond what you can find in its prospectus, and on Morningstar or Yahoo Finance.

Here is what you’ll be able to find in this review:

  • Fact Sheet: HLHIX performance, returns, expense ratio, holdings and dividend yield;
  • Analysis: HLHIX buy or sell; the pros and cons of investing in HLHIX mutual fund;
  • Alternatives: other ETFs and mutual funds you should consider as alternatives to HLHIX.

And here is the list of questions we’ll answer:

  1. Describe Allianz Funds: AllianzGI Health Sciences Fund; Institutional Class Shares (HLHIX).
  2. What are HLHIX holdings?
  3. What is HLHIX performance? What are HLHIX historical returns?
  4. How many up and down years did HLHIX have historically?
  5. What is HLHIX dividend yield?
  6. What is HLHIX minimum initial investment amount?
  7. What is HLHIX expense ratio?
  8. Does HLHIX have any sales loads or 12b-1 distribution expenses?
  9. What is HLHIX tax efficiency (tax-cost ratio)?
  10. What is HLHIX beta? How would you assess HLHIX risk?
  11. What is HLHIX Sharpe ratio?
  12. What is HLHIX Finny Score? HLHIX buy or sell?
  13. What are the pros of investing in HLHIX? What are HLHIX buy reasons?
  14. What are the cons of investing in HLHIX? What are HLHIX sell reasons?

So let’s start. Scroll down to the question that interests you the most.

Fact Sheet

1. Describe Allianz Funds: AllianzGI Health Sciences Fund; Institutional Class Shares (HLHIX).

The Fund seeks long-term capital appreciation by investing at least 65% of its assets in healthcare sector equity securities. Under normal market conditions, the fund will invest at least 65% of its assets will be invested in companies located in at least three different countries, including possibly the United States.

2. What are HLHIX top holdings?

HLHIX has 65 stock holdings and 0 bond holdings.

The top 10 holdings represent 41.47% of total assets. Here are the top holdings:

Name Symbol % Assets
Novartis AG ADR NVS 5.84%
Bristol-Myers Squibb Company BMY 5.40%
Johnson & Johnson JNJ 5.30%
Merck & Co Inc MRK 5.19%
UnitedHealth Group Inc UNH 4.55%
AstraZeneca PLC ADR AZN.L 4.44%
Roche Holding AG ADR RHHBY 3.23%
Boston Scientific Corp BSX 2.62%
Centene Corp CNC 2.49%
AbbVie Inc ABBV 2.41%

3. What is HLHIX performance? What are HLHIX historical returns?

HLHIX has generated the following returns:

  • 1-month return is 9.93%;
  • 3-month return is 0.28%;
  • 1-year return is 22.28%;
  • 3-year return is 12.87%;
  • 5-year return is 8.04%;
  • 10-year return is 14.08%.

4. How many up and down years did HLHIX have historically?

In the last 10 years, HLHIX had 9 up years and 1 down year.

5. What is HLHIX dividend yield?

HLHIX yield is 0.11%.

6. What is HLHIX minimum initial investment amount?

HLHIX minimum initial investment amount is $25.00K.

7. What is HLHIX expense ratio?

HLHIX expense ratio is 1.12%. The expense ratio of a fund is the total percentage of fund assets used for administrative, management, and all other expenses.

8. Does HLHIX have any sales loads or 12b-1 distribution expenses?

HLHIX 12b-1 distribution fee is 0. HLHIX front-end sales load is 0. HLHIX back-end sales load is 0.

9. What is HLHIX tax efficiency (tax-cost ratio)?

  • 1-year ax cost ratio is 1.85%;
  • 3-year ax cost ratio is 1.81%.

10. What is HLHIX beta? How would you assess HLHIX risk?

  • 3-year beta is 0.72;
  • 5-year beta is 0.79;
  • 10-year beta is 0.76.

11. What is HLHIX Sharpe ratio?

  • 3-year Sharpe ratio is 0.50;
  • 5-year Sharpe ratio is 0.33;
  • 10-year Sharpe ratio is 0.83.

Analysis

12. What is HLHIX Finny Score? HLHIX buy or sell?

HLHIX Finny Score is 78. Our quantitative analysis shows 7 reasons to buy HLHIX and 2 reasons to sell it, resulting in the Finny Score of 78.

13. What are the pros of investing in HLHIX? What are HLHIX buy reasons?

The following are HLHIX strengths from our perspective:

  • HLHIX 3-year return is 12.87%, which is higher than the 3-year return of the benchmark index (MSCI World/Health Care NR USD), 10.86%.
  • HLHIX 5-year return is 8.04%, which is higher than the 5-year return of the benchmark index (MSCI World/Health Care NR USD), 6.5%.
  • HLHIX 10-year return is 14.08%, which is higher than the 10-year return of the benchmark index (MSCI World/Health Care NR USD), 12.85%.
  • Good news: this fund does not have 12b1, front-end or back-end sales fees.
  • HLHIX 3-year Beta is 0.72, which is inversely correlated with the index (MSCI ACWI NR USD). The could be good if you're trying to hedge your portfolio.
  • HLHIX 5-year Beta is 0.79, which is inversely correlated with the index (MSCI ACWI NR USD). The could be good if you're trying to hedge your portfolio.
  • HLHIX 10-year Beta is 0.76, which is inversely correlated with the index (MSCI ACWI NR USD). The could be good if you're trying to hedge your portfolio.

14. What are the cons of investing in HLHIX? What are HLHIX negatives?

The following are HLHIX weaknesses from our perspective:

  • HLHIX net assets are $5.00 million. This fund is not a popular choice with retail investors.
  • HLHIX expense ratio is 1.12%, which is not negligible. Is the fund expensive to you, and does it align to your investment strategy?
In the HLHIX review, we covered HLHIX key stats (return, performance, yield, expense ratio, and holdings), buy and sell analysis, and alternative investments. If this review was helpful to you, feel free to check out other mutual fund and ETF reviews.
Follow Us